Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine.
about
Training workshops positively impact beliefs about contingency management in a nationwide dissemination effort.Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.The Place of Adoption in the NIDA Clinical Trials Network.A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.Substance Abuse Counselors' Recovery Status and Self-Schemas: Preliminary Implications for Empirically Supported Treatment ImplementationAdoption of practice guidelines and assessment tools in substance abuse treatmentComparison of opiate-primary treatment seekers with and without alcohol use disorder.Substance abuse treatment providers' involvement in research is associated with willingness to use findings in practice.Counselor attitudes toward the use of motivational incentives in addiction treatment.Implementing evidence-based psychosocial treatment in specialty substance use disorder care.A multilevel approach to predicting community addiction treatment attitudes about contingency managementCorrelates of Motivational Interviewing Use Among Substance Use Treatment Programs Serving American Indians/Alaska Natives.A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatmentSocial workers' knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disordersDisparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.Quality of clinical supervision and counselor emotional exhaustion: the potential mediating roles of organizational and occupational commitmentCounselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.Counselor training and attitudes toward pharmacotherapies for opioid use disorder.Substance abuse counselors' implementation of tobacco cessation guidelinesClinical supervision, emotional exhaustion, and turnover intention: a study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse.Opioid treatment programs in the Clinical Trials Network: representativeness and buprenorphine adoptionThe relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatmentThe science and practice of medication-assisted treatments for opioid dependence.Relationship between Provider Stigma and Predictors of Staff Turnover among Addiction Treatment Providers.Association between addiction treatment staff professional and educational levels and perceptions of organizational climate and resources.Complexities with group therapy facilitation in substance use disorder specialty treatment settings.Group Therapy for Substance Use Disorders: A Survey of Clinician Practices
P2860
Q30222221-D6FDEE3B-553B-4282-8084-EF032F95B09FQ30374904-266FADC6-6B00-40AC-A561-4E790B906C04Q33622979-63A3BE54-2140-44E2-A87A-A56A5C500A2DQ33750845-DDAD9448-93F3-46E0-8919-1FFEC3120C53Q33776944-CB1EE19F-21D7-4DC6-8D75-505A69AE8BB5Q33807361-2967FB79-9FEC-4537-BF6F-F785A26493ECQ33809288-21E67F25-E21B-4624-9076-C345358D827FQ34023147-D9060E43-63DC-41DA-86B6-024A40772508Q34032409-3B331A43-1A4F-4B11-B184-A49F9693E350Q34222652-FFB44C1E-DAEA-4449-9007-A370E4EC7F4FQ35057826-59DDD84F-D9FA-480E-A890-B7641F69DD0DQ35713345-B1442DEE-ECBE-433D-B8AD-80F9E947EA7AQ36290564-9DCC3AA1-D866-49AB-90EA-67D7EABA8CBAQ36364490-FDCB1C4F-461B-46A8-B1F7-9094CCBC6785Q36533966-2619665D-FF72-46F9-8B11-4C75B0A6E9DBQ36597560-1562507B-19A1-493E-8917-2EF27576F4E3Q36699003-01BBEDCB-72A6-45CF-AC1B-10A976363E60Q36914694-0C755C8C-3C3E-498C-A086-3D75C71CB2ECQ36934945-D6ED5016-E31E-4181-979E-2A8477211E39Q36966583-A40CA3CC-6100-43A6-A8BC-57F1AEEB4DAEQ37087541-4CA47FCF-1331-471E-BBF2-D511948C6831Q37352521-AAF4CF01-E023-4887-BB06-BB1C59FBD896Q37419480-B8B11FD3-1607-4361-A65A-81C03A10CA5DQ39223925-2EFE0754-2A8F-4AEF-ADA8-B1313D9128E5Q46790880-B621CE88-6AD1-496F-A2A6-81D7E2136B8DQ50657122-2CEAAAA8-F5FB-469C-81DC-56BE3EBA37A7Q52335191-E8C71FAF-2E0A-49B4-9EFB-FEE0A1305ADFQ57816496-D8836DD2-F723-42C9-A464-DCE35392F137
P2860
Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Research network involvement a ...... ttitudes toward buprenorphine.
@en
Research network involvement a ...... ttitudes toward buprenorphine.
@nl
type
label
Research network involvement a ...... ttitudes toward buprenorphine.
@en
Research network involvement a ...... ttitudes toward buprenorphine.
@nl
prefLabel
Research network involvement a ...... ttitudes toward buprenorphine.
@en
Research network involvement a ...... ttitudes toward buprenorphine.
@nl
P2093
P1476
Research network involvement a ...... ttitudes toward buprenorphine.
@en
P2093
Hannah K Knudsen
Lori J Ducharme
Paul M Roman
P304
P356
10.1080/10550490701525418
P577
2007-09-01T00:00:00Z